245 related articles for article (PubMed ID: 6380350)
1. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
2. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
Reilly DT; Quinton DN; Barrie WW
N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
[TBL] [Abstract][Full Text] [Related]
4. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
Di Perri T; Guerrini M
Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
[TBL] [Abstract][Full Text] [Related]
5. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
7. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.
Roekaerts F; Deleers L
Angiology; 1984 Jul; 35(7):396-406. PubMed ID: 6380348
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
[TBL] [Abstract][Full Text] [Related]
11. Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency.
Ott E; Lechner H; Fazekas F
Eur Neurol; 1983; 22 Suppl 1():105-7. PubMed ID: 6884401
[TBL] [Abstract][Full Text] [Related]
12. On the assessment of the efficacy of pentoxifylline (Trental).
Rössner M; Müller R
J Med; 1987; 18(1):1-15. PubMed ID: 3298515
[TBL] [Abstract][Full Text] [Related]
13. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
[TBL] [Abstract][Full Text] [Related]
14. Does oxpentifylline ('Trental') have a place in the treatment of intermittent claudication?
Donaldson DR; Hall TJ; Kester RC; Ramsden CW; Wiggins PA
Curr Med Res Opin; 1984; 9(1):35-40. PubMed ID: 6373157
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
16. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
17. Pentoxifylline--a new drug for the treatment of intermittent claudication.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
Aviado DM; Dettelbach HR
Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
[TBL] [Abstract][Full Text] [Related]
19. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic treatment of intermittent claudication.
Porter JM; Bauer GM
Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
